Read the 2002 Newsletters 2002, issue 1: Control Conjugates: The Perfect Companion for Targeted Toxins / by Lappi DA / featuring Control Conjugates SFN Poster of the Year Targeting Talk: Toxin Safety Targeting Tools: Serotonin Transporter Antibody 2002, issue 2: HCRT-SAP Lesion Produces Sleepiness While anti-DBH-SAP Lesion Does Not / by Blanco-Centurion C / featuring Anti-DBH-SAP …
Advanced Targeting Systems announces a new reagent for the study of the serotonergic systems—a monoclonal antibody to the serotonin transporter (Cat. #AB-N09). This murine monoclonal is made with a peptide from an extracellular domain of rat serotonin re-uptake transporter (SERT), and thus is able to attach to cells that express SERT. Homology with the human …
Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex. Vogt LJ, Sim-Selley LJ, Childers SR, Wiley RG, Vogt BA. J Pharmacol Exp Ther 299(3):840-848, 2001. PMID: 11714867 The anterior cingulate cortex (ACC) is a primary site of opiate drug action, and much of this activity is associated with the μ-opioid receptor (MOR). The …
Dr. Douglas Lappi, Chief Scientific Officer, Advanced Targeting Systems The field of targeted toxins has made enormous strides in the years since Advanced Targeting Systems introduced the first research targeted toxin in 1994. We now offer 16 different targeted toxins, with more on the way. The number of important papers in high impact journals continues …
Cover Article: Control Conjugates – The Perfect Companion for Targeted Toxins Read More »